Shakopee Dentist Makes Online Appointment Scheduling Easy

Dr. Michael England is pleased to be proving an easy to use appointment request form on his practice's website

2012-12-09

SHAKOPEE, MN, December 09, 2012 (Press-News.org) Dr. Michael England, Shakopee dentist, is providing a simple appointment request form as a part of his practice's comprehensive dental website. By using the online form, patients are now able to request appointments without having to pick up the phone.

"I am very glad that our practice is able to make it easy for patients to request appointments online. We are always striving to make our practice as patient-friendly as possible and this is a great example of that. I hope that many of our patients in the future will use this tool to schedule appointments at our practice," said Dr. England, Shakopee family dentist.

To schedule an appointment with Dr. England for Invisalign in Shakopee or another dental service, patients can either call (952) 746-0808 or use the online appointment request form. To do this, patients simply have to enter in the date, time and a few words detailing the nature of their appointment into the online form. Shortly after this, someone from the practice will follow up with a confirmation of the appointment.

Since Dr. England's website is always available, patients are able to schedule appointments whenever it is convenient for them instead of having to call the practice during regular business hours.

To learn more about Dr. England, his staff or any of the services provided at his practice, patients are encouraged to visit his practice's comprehensive dental website that can be found at http://www.southbridge-dental.com. The site provides a variety of helpful information for patients.

About Southbridge Dental: Dr. Michael England has been practicing since 1977 and established his solo practice, Southbridge Dental, in 2004. He specializes in Invisalign, CEREC, stop snoring appliances, dental veneers, dental implants, interceptive orthodontics, Zoom teeth whitening and an array of other dental treatments and procedures. Southbridge Dental has over 2,300 active patients and employs 8 staff members for optimal dental health care. Dr. Michael England studied at the University of Minnesota, earning his bachelor's degree in biology in 1975 and graduated with his Doctor of Dental Surgery (D.D.S.) in 1977. He has worked in several clinics perfecting his skills before buying an existing practice in Bloomington, prior to opening Southbridge Dental in Shakopee. Dr. England remains active in the Shakopee community and supports Shakopee Derby Days, dental education in the Shakopee schools and participates in the annual Give Kids a Smile Day.

Media Contact:
Dr. Michael England
Southbridgedental@hotmail.com
8074 Old Carriage Ct.
Shakopee, MN 55379
(952) 746-0808
http://www.southbridge-dental.com

ELSE PRESS RELEASES FROM THIS DATE:

V2 Cigs Offers Holiday Discount Coupons On All E-Cigarette Products

2012-12-09

V2 Cigs has been in the business of offering quality e-cigarette products for years now. It has been the trusted brand of most Americans, and has been voted as America's Number 1 Electronic Cigarette by Alexa.com. Being one of the best e cigarette brands in the market, V2 Cigs has an average of one million site visitors every month. So to give back to its millions of customers and supporters, V2 Cigs has partnered with EcigaretteReviewed.com to offer huge discounts on all of the brand's products in time for Christmas. V2 Cigs has already dropped its prices for the coming ...

Online Bingo at Its Best, Thanks to Bingo Reviewer!

2012-12-09

There's quite a mishmash of bingo sites, different offers, warnings about some venues, good and bad player reviews, forum posts, bonuses and other features that new players should take into consideration before they can feel confident they've made the right choice of the online bingo room where they'll deposit their money and play. In such a jungle where experience is an essential tool, there's a ray of light that delivers hope for those who are not willing to experiment and risk their money on just any bingo site; and the ray comes in shape of online bingo resource ...

Film Vet Ashaine Briscoe Enters the Spotlight with Quirky, Heartfelt New Shorts

2012-12-09

Filmmaker Ashaine Briscoe has just made her debut as a screenwriter, director, and producer--but to call her a novice would be an incredible oversight. In reality, Briscoe has been working in film for years, developing an almost preternaturally accomplished and diverse resume that includes credits as a Production Assistant, an Art Director, and more. She has worked on TV commercials and music videos, and her keen eye and visual flair have landed her design spots in leading glamour magazines. Now, however, it is Briscoe's time to shine, and to unleash the full extent of ...

Investigational agent targets gene signaling pathways to improve response for patients with CLL

2012-12-08

(ATLANTA, December 8, 2012) –The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic lymphocytic leukemia (CLL), according to studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH). CLL is a blood cancer that causes abnormal white blood cells called lymphocytes to accumulate in the blood, bone marrow, and in the lymph nodes or other organs, causing these organs to enlarge. Approximately 15,000 ...

Researchers develop novel 3-D culture system for inflammatory breast cancer

2012-12-08

SAN ANTONIO, TX (December 8, 2012)—Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment. Researchers at Fox Chase Cancer Center have developed a novel, 3D culture system that mimics the environment surrounding these cancer cells. This model could be used to test new anticancer drugs capable of inhibiting the spread of IBC tumors. "The tumor ...

Studies assess genetics, modified treatment to improve outcomes, reduce toxicity

2012-12-08

(ATLANTA, December 8, 2012) – Research identifying genetic factors that affect survival of patients with blood cancers and evaluating the effectiveness of modified treatment strategies to improve outcomes while reducing toxicity will be presented today at the 54th Annual Meeting of the American Society of Hematology (ASH). While the cancer research community has seen many significant therapeutic advances over the last decade, only recently have investigators identified how patients' individual genetic makeup influences their short- and long-term response to therapy, demonstrating ...

Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients

2012-12-08

COLUMBUS, Ohio – Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy. The agent, ibrutinib (PCI-32765), is the first drug designed to target Bruton's tyrosine kinase (BTK), a protein essential for CLL-cell survival and proliferation. CLL is the most common form of leukemia, with about 15,000 new cases annually in the U.S. About 4,400 Americans die of the disease each year. Study co-leader Dr. ...

137 new species described by California Academy of Sciences in 2012

2012-12-08

SAN FRANCISCO (December 6, 2012) — In 2012, researchers at the California Academy of Sciences added 137 new relatives to our family tree, enriching our understanding of the complex web of life on Earth and strengthening our ability to make informed conservation decisions. The new species include 83 arthropods, 41 fishes, seven plants, four sea slugs, one reptile, and one amphibian. Specimens ranged from Eviota goby fishes housed in museum collections for more than 30 years (reported in the October 12 issue of Zootaxa), to Trogloraptor cave spiders collected just two years ...

Mayo Clinic IDs genes that predict whether trastuzumab will work for breast cancer patients

2012-12-08

SAN ANTONIO, Texas -- Adding the drug trastuzumab to chemotherapy prevents cancer recurrence and improves survival in a large number of women with early stage HER2-positive breast cancer. But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment. This situation may soon change, according to a Mayo Clinic study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium. VIDEO ALERT: Video of Dr. Perez is available on the Mayo Clinic News Network. A team ...

New small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer

2012-12-08

SAN ANTONIO, TX (December 7, 2012)—Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor. Mesupron® is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a recent phase II clinical study suggest that the drug could be a safe and first-line treatment that extends progression-free survival for metastatic ...

Shakopee Dentist Makes Online Appointment Scheduling Easy

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: